Tagged with Healthcare,

Diversity Annually, PharmaBoardroom conducts hundreds of interviews with global CEO’s, country managers and industry leaders in the pharma industry. While we have crossed paths with many inspiring females in these positions, out of the top 50 pharma companies, only 3 are headed by women. That is a mere 6% — this…

Spain Having largely recovered from the impact of the global financial crisis and with several impressive fundamentals in place, Spain once again stands as one of Europe’s premier healthcare and life science investment destinations.   These fundamentals include a revamped market access process that puts the Iberian nation on a par…

Korea * This interview was conducted before GE’s announcement of its divestment of the GE Biopharma business Francis Van Parys, president & CEO of GE Healthcare Korea discusses their ambitions to roll out further AI-powered solutions to within the Korean market and their manufacturing footprint locally. Mr Van Parys also comments…

France In an exclusive interview, Dominique Le Guludec, president of the French National Authority for Health (Haute Autorité de Santé (HAS)), offers her insider comments on the changes in French healthcare policy under President Emmanuel Macron.   The integration of this entire sector completely resonates with our vision of a comprehensive…

Turkey Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on hospital investment.   Throughout many of the healthcare systems in North America and Europe, there is an increasing emphasis on outpatient and preventative care. In terms of health economics, governments see a great benefit in…

Korea The administration of President Moon Jae-in is moving to ensure the enduring success of South Korea’s healthcare and life sciences industries through increased international collaboration. However, some pharma insiders are calling for even greater governmental support for what is still a tightly regulated sector facing pressures over pricing, exacerbated partly…

Spain Dr Antonio Alarco gives his insider take on the future of Spanish healthcare, personalized medicine, and the areas in which Spain needs to improve.   Innovation is the best investment; there will never be a real change without popular scientific divulgation With Mariano Rajoy of the People’s Party (PP) stepping…

Turkey Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city hospitals project, highlighting the strengths of the Turkish PPP model and ultimately offering her view on the state of the Turkish medical devices industry as a whole.   Turkey is an important…

Spain Carlos Rus Palacios, general secretary of the Alliance of Spanish Private Healthcare (ASPE), the association of private hospitals and private health centers in Spain, delivers his message on the importance of the private sector within Spain’s healthcare system and the shift in mindset that must be realized by health stakeholders…

Spain Luis Campo, CEO of GE Healthcare Spain & Portugal, discusses the opportunities and challenges inherent in the Spanish healthcare system and the ways in which GE is collaborating with authorities to bring innovative solutions to Spanish patients.   GE Healthcare is pioneering the concept of a hospital Command Centre, learning…

UK The two Big Pharma giants today announced the merger between their consumer healthcare businesses, with the joint venture (JV) set to become the global market leader in over-the-counter (OTC) products with a market share of 7.3 percent.   This move will see GSK effectively split into two separate businesses –…

Korea Yong-Ik Kim, president of Korea’s National Health Insurance Service (NHIS), provides an insight into the implementation of the upcoming MoonCare reforms, the government’s strategy to ensure the expansion of coverage is achieved sustainably, and the task of balancing affordable drug prices and encouraging innovation.   What are the main challenges…